Abbott and NIH Join Forces to Advance Neuroscience Research
Abbott Laboratories and the National Institutes of Health have formed an alliance to evaluate applications that could help treat chronic pain and progressive movement disorders, like Parkinsonâs disease.
The collaboration is a part of NIHâs BRAIN (Brain Research through Advancing Innovative Neurotechnologies) initiative to accelerate advancements in neuroscience research. The agreement specifically calls for NIH to use the Abbott Park, IL-based companyâs neuromodulation technologies for research related to these NIH initiatives to explore their application for chronic pain and progressive movement disorders, like Parkinsonâs disease.
The BRAIN Initiative was launched in 2013 and looks to understand the functions of the human brain by researching and developing new uses for innovative technologies. Recently, the BRAIN Initiative assembled participants from contributing federal agencies, non-federal organizations, as well as members of the media, public, and Congress at its 5th Annual Investigators Meeting in Washington, D.C. The meeting provided a forum for discussing recent scientific developments and potential new directions in brain research and identified areas for collaboration and research coordination.
âFor Abbott this is a golden opportunity,â Binith Cheeran, Medical Director in Abbottâs Neuromodulation, told MD+DI. âWe want to...
Source: MDDI - Category: Medical Devices Authors: Omar Ford Tags: R & D Source Type: news
More News: Back Pain | Brain | Chronic Pain | Deep Brain Stimulation | Ganglions | Medical Devices | Mergers and Aquisitions | National Institutes of Health (NIH) | Neurology | Neuroscience | Pain | Parkinson's Disease | Politics | Stroke